Pre-exposure prophylaxis (PrEP) can reduce the risk of infections in HIVseronegative persons at substantial risk, as long as it is taken as prescribed.
Use of PrEP as an additional prevention option has the potential to reduce HIV transmission and contribute to reversing the increase in new infections in Europe.
France is the only country in Europe currently providing PrEP through public health services, but a number of other countries are implementing or planning to implement PrEP demonstration projects.
Use of antiretroviral medication for PrEP has been approved in the European Union, but countries cite the cost of drugs as a key barrier to provision of PrEP by public health services
7 views0 comments